Fluzone QIV HD is under clinical development by Sanofi and currently in Phase II for Unspecified Influenza Virus Infections.

The announcement follows just days after the US Centres for Disease Control confirmed its first death from the zoonotic ...

With sales of its COVID-19 vaccines on the wane, Moderna has showcased the projects it will look to for the next phase of its development, headed by new vaccines for influenza and respiratory ...

The seasonal surge of respiratory viruses are here—and no one wants to miss out on any fun because they’re sick. Vaccines and antiviral drugs have made COVID-19 (and the flu) more manageable ...

Moderna says it has become the first company in the pharma sector with phase 3 data on a combined vaccine for both COVID-19 and influenza and will soon be ready to discuss “next steps” with ...

Traveling by plane? Dining out? Going to a wedding? These tips can help you avoid COVID-19, colds, and more. By Hallie Levine The seasonal surge of respiratory viruses are here—and no one wants ...

The company’s vaccine candidate, also known as LUNAR-H5N1, will be examined in a randomised placebo-controlled trial in 200 healthy adults. Credit: Shutterstock / Mr. Kosal California vaccine company ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.